- Conflicts of interest comprise those which may not be fully apparent and which may influence the judgment of author, reviewers, and editors. They have been described as those which, when revealed later, would make a reasonable reader feel misled or deceived. They may be personal, commercial, political, academic or financial.
- “Financial” interests may include employment, research funding, stock or share ownership, payment for lectures or travel, consultancies and company support for staff.
- "Conflict of Interest" is required for all types of submissions.
- Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future.
- Authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript.
Authors must declare in CoI:
Conflict of Interests must be included in this text box (during submission) to prevent overlooked or misplaced information on potential conflict of interests. Authors must identify any potential financial conflict of interests before the review process begins. Declared conflict of interest will not automatically result in rejection of a paper but the editors reserve the right to publish any declared conflict of interest alongside the acceptance. The following statements would generally be regarded as potential conflict of interests:
- Direct financial payment to an author for the research or manuscript production by the sponsor of a product or service evaluated in an article.
- Ownership of shares by an author in the company sponsoring a product service evaluated in an article (or in a company sponsoring a competing product).
- Personal consultant for companies or other organizations with a financial interests for promotion of particular health care products and services.
Dr A BBB reported receiving research grants and honoraria and consulting fees for speaking from X Company and Y. Dr CCC reported receiving honoraria from Z company and P.
CoI in Authors from Commercial organizations
- Authors from a pharmaceutical company that sponsor any clinical trial, must declare their interest during submission in the "CoI". They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies (GPP3), which are designed to ensure that publications are produced in a responsible and ethical manner.
- The guidelines also apply to any companies or individuals that work on industry-sponsored publications, such as freelance writers, contract research organizations and communications companies.
- Kowsar will not publish advertorial content.
Approach to undisclosed CoI before Publishing
Approach to undisclosed CoI after Publishing
- Based on this COPE flowchart:
- If authors denied any CoI: Inform readers by Retraction of the article.
- If authors supplied the relevant details: Publish a correction to competing interest statement by EIC as required.